Loading...

Spine Wave Announces the Commercial Launch of the Paramount® Anterior Cervical Cage

SHELTON, Conn., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Spine Wave is pleased to announce the commercial launch of the Paramount® Anterior Cervical Cage.  The Paramount® Anterior Cervical Cage is a titanium anterior cervical implant with integrated fixation blades.  The patented system offers controlled, less invasive blade deployment and maximized bone grafting.  The Paramount® Anterior Cervical

By |2018-09-17T22:37:11+00:00September 17th, 2018|Spine|

Simplify® Medical Technology Selected for Innovative Technology Paper at NASS 2018 Annual Meeting

SUNNYVALE, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Simplify Medical Pty Ltd, maker of the Simplify® cervical artificial disc, announced today that an abstract for preliminary data from the Company’s 1-level Investigational Device Exemption (IDE) clinical trial has been selected as an Innovative Technology Presentation during the 2018 North American Spine Society (NASS) Annual Meeting,

By |2018-09-17T17:24:40+00:00September 17th, 2018|Spine|

SpineVision® Receives FDA Clearance and CE Mark for Next-Gen Titanium 3D-Printed HEXANIUM TLIF Cage

September 17, 2018 ANTONY, France--(BUSINESS WIRE)--SpineVision announced today that it has received FDA clearance and CE mark for its next-generation titanium 3D laser-printed HEXANIUM TLIF (Transforaminal Lumbar Interbody Fusion) cage for back surgery. SpineVision will introduce its new product to spine surgeons at “EuroSpine 2018”(Booth #24C) in Barcelona, Spain (Sept. 19-21), and “NASS 2018” (Booth #1311) in Los Angeles (Sept. 26-29). Spine fusion surgery is often

By |2018-09-17T14:55:44+00:00September 17th, 2018|Regulatory, Spine, Top Stories|

Bone Therapeutics SA announces final results from Phase I/IIA ALLOB delayed-union fracture study

Gosselies, Belgium, 14 September 2018, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces positive final results in the Phase I/IIA delayed-union study of its allogeneic bone cell therapy product ALLOB in 21 patients, supporting the future

By |2018-09-14T22:25:09+00:00September 14th, 2018|Biologics|

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2018

WARSAW, Ind., Sept. 13, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2018. The cash dividend of $0.24 per share is payable on October 31, 2018 to stockholders of record

By |2018-09-14T22:08:03+00:00September 14th, 2018|Financial|

AMDT Holdings, Inc. Gains FDA Clearance for the SixFix™ System

COLLIERVILLE, Tenn., Sept. 5, 2018 /PRNewswire/ -- AMDT Holdings, Inc. (AMDT) is pleased to announce FDA clearance for their patented SixFix deformity analysis and correction software and instrumentation. AMDT Holdings, Inc. develops new products to address the existing and emerging needs of the multi-billion-dollar extremity medical device market. Spatial frame fixators usually consist of two rings connected

By |2018-09-14T18:24:57+00:00September 14th, 2018|Extremities, Regulatory|

EOS imaging Reports First Half 2018 Financial Results

September 13, 2018 PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI - Eligible PEA - SME), the pioneer of 2D/3D imaging and data solutions for orthopedics, today announced its consolidated results for the six months ended June 30, 2018, as stated by the Board of Directors on September 12, 2018. First Half 2018 Financial

By |2018-09-14T17:40:04+00:00September 14th, 2018|Financial|

Global Spine Market to Reach $18 Billion by 2023 According to New Analysis by iData Research

September 13, 2018 VANCOUVER, British Columbia--(BUSINESS WIRE)--According to a new series of reports by iData Research, the global spine market is valued at over $14.4 billion USD and is projected to approach $18 billion by 2023. Researched regions include the United States, 15 countries in Europe, 3 countries in Latin America, and 5 countries in

By |2018-09-14T17:10:19+00:00September 14th, 2018|Financial, Spine|

Globus Medical Acquires Surgimap®

AUDUBON, Pa., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the acquisition of Nemaris Inc., a privately held company that markets and develops Surgimap®, a leading surgical planning software platform. Surgimap® allows healthcare professionals to simulate potential surgical outcomes and share medical imaging globally to improve

By |2018-09-14T15:48:35+00:00September 14th, 2018|Spine, Top Stories|

Benvenue Medical Completes Divestiture of its Vertebral Augmentation Systems Portfolio

September 13, 2018 SANTA CLARA, Calif.--(BUSINESS WIRE)--Benvenue Medical, Inc., a developer of minimally invasive expandable implant solutions for lumbar fusion, today announced it has completed the divestiture of its vertebral augmentation systems portfolio for an undisclosed amount to IZI Medical Products, LLC. The completion of the sale of this business allows Benvenue Medical to devote

By |2018-09-14T15:16:25+00:00September 14th, 2018|Spine, Top Stories|